11 Results

People

  1. Korde
    Korde
  2. Mailankody
    Mailankody
  3. Hassoun
    Hassoun
  4. Lesokhin
    Lesokhin
  5. Landgren
    Landgren
  6. Chung
    Chung
  7. Giralt
    Giralt
  8. Hultcrantz
    Hultcrantz
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies Research (11)
  4. Hematologic Malignancies, Division of (11)
  5. Myeloma (11)
  6. Survivorship Research (11)
  7. Sloan Kettering Institute Postdocs (8)
  8. Bone Marrow Transplant (7)
  9. CTCR Scholars (7)
  10. Epidemiology and Biostatistics (7)
  1. "article"
  2. "Hematologic Malignancies Research"
  3. "Neha Korde"
  4. "Sham Mailankody"
Formats
  1. Journal Article (11)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies Research (11)
  4. Hematologic Malignancies, Division of (11)
  5. Myeloma (11)
  6. Survivorship Research (11)

More Groups

People
  1. Neha Korde (11)
  2. Sham Mailankody (11)
  3. Alexander Lesokhin (9)
  4. Hani Hassoun (9)
  5. Carl Landgren (8)
  6. Malin Hultcrantz (8)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. American Journal of Hematology (1)
  2. Blood Advances (1)
  3. Blood Cancer Journal (1)
  4. British Journal of Haematology (1)
  5. Cancer Chemotherapy and Pharmacology (1)
  6. Clinical Biochemistry (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. American Medical Association (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
    Journal Article

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Lu, S.; Shah, U.; Hassoun, H.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save